Frankfurt - Delayed Quote EUR

4SC AG (VSC.F)

2.4800
0.0000
(0.00%)
As of 9:15:34 AM GMT+2. Market Open.
Currency in EUR All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
336
336
304
436
14,109
Cost of Revenue
84
84
95
155
383
Gross Profit
252
252
209
281
13,726
Operating Expense
8,485
8,485
8,635
13,960
21,969
Operating Income
-8,233
-8,233
-8,426
-13,679
-8,243
Net Non Operating Interest Income Expense
-91
-91
159
0
3
Pretax Income
-8,326
-8,326
-8,222
-14,361
-9,628
Tax Provision
8
8
15
0
0
Net Income Common Stockholders
-8,334
-8,334
-8,237
-14,361
-9,628
Diluted NI Available to Com Stockholders
-8,334
-8,334
-8,237
-14,361
-9,628
Basic EPS
-0.76
-0.76
-0.81
-1.42
-0.95
Diluted EPS
-0.76
-0.76
-0.81
-1.42
-0.95
Basic Average Shares
10,965.7890
10,965.7890
10,169.1360
10,113.3800
10,134.7370
Diluted Average Shares
10,965.7890
10,965.7890
10,169.1360
10,113.3800
10,134.7370
Total Operating Income as Reported
--
--
--
--
-8,650
Rent Expense Supplemental
--
--
--
--
37
Total Expenses
8,569
8,569
8,730
14,115
22,352
Net Income from Continuing & Discontinued Operation
-8,334
-8,334
-8,237
-14,361
-9,628
Normalized Income
-8,333.1500
-8,333.1500
-8,275.2500
-13,754
-8,231
Interest Income
214
214
262
0
4
Interest Expense
305
305
103
0
1
Net Interest Income
-91
-91
159
0
3
EBIT
-8,021
-8,021
-8,119
-14,361
-9,627
EBITDA
-7,507
-7,507
-7,588
-12,593
-8,776
Reconciled Cost of Revenue
84
84
95
155
383
Reconciled Depreciation
514
514
531
1,768
851
Net Income from Continuing Operation Net Minority Interest
-8,334
-8,334
-8,237
-14,361
-9,628
Total Unusual Items Excluding Goodwill
-1
-1
45
-607
-1,397
Total Unusual Items
-1
-1
45
-607
-1,397
Normalized EBITDA
-7,506
-7,506
-7,633
-11,986
-7,379
Tax Rate for Calcs
0.0002
0.0002
0.0002
0
0
Tax Effect of Unusual Items
-0.1500
-0.1500
6.7500
0
0
12/31/2021 - 12/15/2005

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

MDG1.SG Medigene AG
0.1085
-4.82%
 
GON.SG Geron Corp
1.0380
-1.56%
 
BIOV.SW BioVersys N
34.70
0.00%
 
MDG1.DE Medigene AG
0.1335
-27.64%
 
HPHA.DE Heidelberg Pharma AG
3.2500
+4.17%
 
ALTME.PA TME Pharma N.V.
0.0722
+0.28%
 
BSLN.SW Basilea Pharmaceutica AG
43.40
-0.12%
 
NYKD.OL Nykode Therapeutics AS
2.7040
-2.87%
 
VVY.AS Vivoryon Therapeutics N.V.
1.7200
-1.94%
 
ALCLS.PA Cellectis S.A.
1.3580
+4.14%